In The News Articles

Featured Article

Atomwise Receives a $2.3M Grant to Develop New Therapies for Drug Resistant Malaria and Tuberculosis

The $2.3M in grant funding from the Bill & Melinda Gates Foundation will support the development of multiple global health programs to advance novel antimalarial and anti-tuberculosis small molecule therapies in collaboration with the foundation’s global network SAN FRANCISCO, CA -- October 6th, 2020 -- Atomwise, the leader in using artificial intelligence (AI) for small...

Read Article

October 6, 2020

Atomwise Receives a $2.3M Grant

In The News

[VC News Daily] Atomwise announced today $2.3M in grant funding for AI-based discovery of antimalarial and anti-tuberculosis therapies.

Read Article

October 2, 2020

Introducing AI/ML In the Life Sciences

In The News

[Global Business Reports] When MIT mathematician Jim Simmons founded Renaissance Technologies in 1988, it was unfathomable that computers driven by algorithms might outperform top Wall Street fund managers. Today, after a more than thirty year average return of 66% per annum, the Renaissance model of applying machine learning techniques to invest in a manner that […]

Read Article

September 29, 2020

A short guide for medical professionals in the era of artificial intelligence

In The News

[Nature] Artificial intelligence (A.I.) is expected to significantly influence the practice of medicine and the delivery of healthcare in the near future. While there are only a handful of practical examples for its medical use with enough evidence, hype and attention around the topic are significant. There are so many papers, conference talks, misleading news […]

Read Article

September 24, 2020

Biopharm America: Bayer investing advances by Leaps and no boundaries

In The News

[BioWorld] Deals by Bayer AG’s “impact investment unit” called Leaps that build upon each other let the Leverkusen, Germany-based firm “basically renew [the company’s] technology platform” by tapping fresh sources, said Leaps head Jurgen Eckhardt. And the unit is casting nets widely.

Read Article

September 23, 2020

GC Pharma, Atomwise Aim for Potential Oral Hemophilia Therapies

In The News

[Hemophilia News Today] Atomwise, a company that specializes in using artificial intelligence (AI) to develop small molecule medicines, will partner with GC Pharma to discover new ways of treating people with hemophilia.

Read Article

Events

Oct 25-29, 2020

BIO-Europe

Digital Conference
Nov 6, 2020

AUTM Webinar

Virtual Webinar
Dec 2-4, 2020

Web Summit 2020

Virtual Conference

Publications

August 18, 2020

Artificial Intelligence for COVID-19 Drug Discovery and Vaccine Development

Arash Keshavarzi Arshadi, Julia Webb, Milad Salem, Emmanuel Cruz, Stacie Callad-Thomson, Niloofar Ghadirian, Jennifer Collins, Elen Diez-Cecilia, Brendan Kelly, Hani Goodarzi, and Jiann Shiun Yuan
August 17, 2020

Current methods and challenges for deep learning in drug discovery

Stefan Schroedl
July 30, 2020

Discovery of Novel Inhibitors of a Critical Brain Enzyme Using a Homology Model and a Deep Convolutional Neural Network

Adrian Stecula, Muhammad S. Hussain, Ronald E. Viola
July 30, 2020

Small molecules block the interaction between porcine reproductive and respiratory syndrome virus and CD163 receptor and the infection of pig cells

Chang Huang, Denzil Bernard, Jiaqi Zhu, Radha Charan Dash, Alexander Chu, Alec Knupp, Anna Hakey, M. Kyle Hadden, Antonio Garmendia, Young Tang
September 26, 2019

Miro1 Marks Parkinson’s Disease Subset and Miro1 Reducer Rescues Neuron Loss in Parkinson’s Models

Chung-Han Hsieh, Li Li, Roeland Vanhauwaert, Kong T. Nguyen, Mary D. Davis, Guojun Bu, Zbigniew K. Wszolek, Xinnan Wang